This work is licensed under the Creative Commons Attribution 4.0 International License.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 2021; 71: 209-49. doi: 10.3322/caac.21669SungHFerlayJSiegelRLLaversanneMSoerjomataramIJemalAet alGlobal cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries2021712094910.3322/caac.2166934232515Open DOISearch in Google Scholar
Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet 2018; 143(Suppl 2): S22-36. doi: 10.1002/ijgo.13865BhatlaNAokiDSharmaDNSankaranarayananRCancer of the cervix uteri2018143Suppl 2S223610.1002/ijgo.13865929821334669203Open DOISearch in Google Scholar
Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, et al. Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006; 95(Suppl 1): S43-103. doi: 10.1016/S0020-7292(06)60030-1QuinnMABenedetJLOdicinoFMaisonneuvePBellerUCreasmanWTet alCarcinoma of the cervix uteri200695Suppl 1S4310310.1016/S0020-7292(06)60030-129644676Open DOISearch in Google Scholar
Thomas GM, Dembo AJ, Myhr T, Black B, Pringle JF, Rawlings G. Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery. Int J Gynecol Cancer 1993; 3: 193-8. doi: 10.1046/j.1525-1438.1993.03040193.xThomasGMDemboAJMyhrTBlackBPringleJFRawlingsGLong-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery19933193810.1046/j.1525-1438.1993.03040193.x11578344Open DOISearch in Google Scholar
Gandy N, Arshad MA, Park WE, Rockall AG, Barwick TD. FDG-PET Imaging in cervical cancer. Semin Nucl Med 2019; 49: 461-70. doi: 10.1053/j.semnu-clmed.2019.06.007.GandyNArshadMAParkWERockallAGBarwickTDFDG-PET Imaging in cervical cancer2019494617010.1053/j.semnu-clmed.2019.06.007Open DOISearch in Google Scholar
Patel-Lippmann K, Robbins JB, Barroilhet L, Anderson B, Sadowski EA, Boyum J. MR imaging of cervical cancer. Magn Reson Imaging Clin N Am 2017; 25: 635-49. doi: 10.1016/j.mric.2017.03.007Patel-LippmannKRobbinsJBBarroilhetLAndersonBSadowskiEABoyumJMR imaging of cervical cancer2017256354910.1016/j.mric.2017.03.00728668164Open DOISearch in Google Scholar
Palaniswamy SS, Borde CR, Subramanyam P. 18F-FDG PET/CT in the evaluation of cancer cervix: where do we stand today? Nucl Med Commun 2018; 39: 583-92. doi: 10.1097/MNM.0000000000000851PalaniswamySSBordeCRSubramanyamP18F-FDG PET/CT in the evaluation of cancer cervix: where do we stand today?2018395839210.1097/MNM.000000000000085129683929Open DOISearch in Google Scholar
Vinh-Hung V, Bourgain C, Vlastos G, Cserni G, De Ridder M, Storme G et al. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer 2007; 7: 164. doi:10.1186/1471-2407-7-164Vinh-HungVBourgainCVlastosGCserniGDe RidderMStormeGet alPrognostic value of histopathology and trends in cervical cancer: a SEER population study2007716410.1186/1471-2407-7-164199495417718897Open DOISearch in Google Scholar
Cancer.Net. Cervical Cancer: Statistics. [Internet]. American Society of Clinical Oncology (ASCO); c2005-21. [cited 2021 Aug 17]. Available from: https://www.cancer.net/cancer-types/cervical-cancer/statisticsc2005-21. [cited 2021 Aug 17]. Available fromhttps://www.cancer.net/cancer-types/cervical-cancer/statisticsSearch in Google Scholar
Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer 2007; 110: 1738-44. doi: 10.1002/cncr.22974KiddEASiegelBADehdashtiFGrigsbyPWThe standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival200711017384410.1002/cncr.2297417786947Open DOISearch in Google Scholar
Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, et al. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol 2010; 28: 2108-13. doi: 10.1200/JCO.2009.25.4151KiddEASiegelBADehdashtiFRaderJSMutchDGPowellMAet alLymph node staging by positron emission tomography in cervical cancer: relationship to prognosis20102821081310.1200/JCO.2009.25.415120308664Open DOISearch in Google Scholar
Yen TC, See LC, Lai CH, Tsai CS, Chao A, Hsueh S, et al. Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer. Eur J Nucl Med Mol Imaging 2008; 35: 493-501. doi: 10.1007/s00259-007-0612-1YenTCSeeLCLaiCHTsaiCSChaoAHsuehSet alStandardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer20083549350110.1007/s00259-007-0612-117955238Open DOISearch in Google Scholar
Han S, Kim H, Kim YJ, Suh CH, Woo S. Prognostic value of volume-based metabolic parameters of 18F-FDG PET/CT in uterine cervical cancer: a systematic review and meta-analysis. AJR Am J Roentgenol 2018; 211: 1112-21. doi: 10.2214/AJR.18.19734HanSKimHKimYJSuhCHWooSPrognostic value of volume-based metabolic parameters of 18F-FDG PET/CT in uterine cervical cancer: a systematic review and meta-analysis201821111122110.2214/AJR.18.1973430207790Open DOISearch in Google Scholar
Miccò M, Vargas HA, Burger IA, Kollmeier MA, Goldman DA, Park KJ, et al. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. Eur J Radiol 2014; 83: 1169-76. doi: 10.1016/j.ejrad.2014.03.024MiccòMVargasHABurgerIAKollmeierMAGoldmanDAParkKJet alCombined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer20148311697610.1016/j.ejrad.2014.03.02424767630Open DOISearch in Google Scholar
Ho JC, Allen PK, Bhosale PR, Rauch GM, Fuller CD, Mohamed AS, et al. Diffusion-weighted magnetic resonance imaging as a predictor of outcome in cervical cancer after chemoradiation. Int J Radiat Oncol Biol Phys 2017; 97: 546-53. doi: 10.1016/j.ijrobp.2016.11.015HoJCAllenPKBhosalePRRauchGMFullerCDMohamedASet alDiffusion-weighted magnetic resonance imaging as a predictor of outcome in cervical cancer after chemoradiation2017975465310.1016/j.ijrobp.2016.11.015611261228011045Open DOISearch in Google Scholar
Tavassoéli FA, Devilee P. IARC WHO classification of tumours, pathology and genetics tumours of the breast and female genital organs. Vol 4. 3rd edition. Lyon: IARC publications; 2003.TavassoéliFADevileePLyonIARC publications;2003Search in Google Scholar
Kurman RJ, Hedrick-Ellenson L, Ronnett BM. Blaustein’s pathology of the female genital tract. 6th edition. New York: Springer; 2011.KurmanRJHedrick-EllensonLRonnettBMNew YorkSpringer201110.1007/978-1-4419-0489-8Search in Google Scholar
Meads C, Davenport C, Małysiak S, Kowalska M, Zapalska A, Guest P, et al. Evaluating PET-CT in the detection and management of recurrent cervical cancer: systematic reviews of diagnostic accuracy and subjective elicitation. BJOG 2014; 121: 398-407. doi: 10.1111/1471-0528.12460MeadsCDavenportCMałysiakSKowalskaMZapalskaAGuestPet alEvaluating PET-CT in the detection and management of recurrent cervical cancer: systematic reviews of diagnostic accuracy and subjective elicitation201412139840710.1111/1471-0528.1246024299112Open DOISearch in Google Scholar
Chu Y, Zheng A, Wang F, Lin W, Yang X, Han L, et al. Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis. Nucl Med Commun 2014; 35: 144-50. doi: 10.1097/MNM.0000000000000026ChuYZhengAWangFLinWYangXHanLet alDiagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis2014351445010.1097/MNM.000000000000002624177043Open DOISearch in Google Scholar
Pallardy A, Bodet-Milin C, Oudoux A, Campion L, Bourbouloux E, Sagan C, et al. Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma. Eur J Nucl Med Mol Imaging 2010; 37: 1270-8. doi: 10.1007/s00259-010-1417-1PallardyABodet-MilinCOudouxACampionLBourboulouxESaganCet alClinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma2010371270810.1007/s00259-010-1417-120306032Open DOISearch in Google Scholar
Bjurberg M, Brun E. Clinical impact of 2-deoxy-2-[18F] fluoro-D-glucose (FDG)-positron emission tomography (PET) on treatment choice in recurrent cancer of the cervix uteri. Int J Gynecol Cancer 2013; 23: 1642-6. doi: 10.1097/IGC.0b013e3182a50537BjurbergMBrunEClinical impact of 2-deoxy-2-[18F] fluoro-D-glucose (FDG)-positron emission tomography (PET) on treatment choice in recurrent cancer of the cervix uteri2013231642610.1097/IGC.0b013e3182a5053724177254Open DOISearch in Google Scholar
Lai CH, Huang KG, See LC, Yen TC, Tsai CS, Chang TC, et al. Restaging of recurrent cervical carcinoma with dual-phase [18F] fluoro-2-deoxy-D-glucose positron emission tomography. Cancer 2004; 100: 544-52. doi: 10.1002/cncr.11928LaiCHHuangKGSeeLCYenTCTsaiCSChangTCet alRestaging of recurrent cervical carcinoma with dual-phase [18F] fluoro-2-deoxy-D-glucose positron emission tomography20041005445210.1002/cncr.1192814745871Open DOISearch in Google Scholar
Yen TC, Lai CH, Ma SY, Huang KG, Huang HJ, Hong JH, et al. Comparative benefits and limitations of 18F-FDG PET and CT-MRI in documented or suspected recurrent cervical cancer. Eur J Nucl Med Mol Imaging 2006; 33: 1399-407. doi: 10.1007/s00259-006-0090-xYenTCLaiCHMaSYHuangKGHuangHJHongJHet alComparative benefits and limitations of 18F-FDG PET and CT-MRI in documented or suspected recurrent cervical cancer200633139940710.1007/s00259-006-0090-x16847653Open DOISearch in Google Scholar
Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol 2004; 22: 2167-71. doi: 10.1200/JCO.2004.09.035GrigsbyPWSiegelBADehdashtiFRaderJZoberiIPosttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome20042221677110.1200/JCO.2004.09.03515169804Open DOISearch in Google Scholar
Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA 2007; 298: 2289-95. doi: 10.1001/jama.298.19.2289SchwarzJKSiegelBADehdashtiFGrigsbyPWAssociation of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma200729822899510.1001/jama.298.19.228918029833Open DOISearch in Google Scholar
Kim YJ, Han S, Kim YS, Nam JH. Prognostic value of post-treatment 18F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis. J Gynecol Oncol 2019; 30: e66. doi: 10.3802/jgo.2019.30.e66.KimYJHanSKimYSNamJHPrognostic value of post-treatment 18F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis201930e6610.3802/jgo.2019.30.e66665859731328452Open DOISearch in Google Scholar
Onal C, Guler OC, Reyhan M, Yapar AF. Long-term outcomes of cervical cancer patients with complete metabolic response after definitive chemoradiotherapy. J Gynecol Oncol 2021; 32: e74. doi: 10.1016/j.clon.2021.03.022OnalCGulerOCReyhanMYaparAFLong-term outcomes of cervical cancer patients with complete metabolic response after definitive chemoradiotherapy202132e7410.1016/j.clon.2021.03.02233906779Open DOISearch in Google Scholar
Chung HH, Kim JW, Kang KW, Park NH, Song YS, Chung JK, et al. Predictive role of post-treatment [18F] FDG PET/CT in patients with uterine cervical cancer. Eur J Radiol 2012; 81: e817-e822. doi: 10.1016/j.ejrad.2012.02.015ChungHHKimJWKangKWParkNHSongYSChungJKet alPredictive role of post-treatment [18F] FDG PET/CT in patients with uterine cervical cancer201281e817e82210.1016/j.ejrad.2012.02.01522595504Open DOISearch in Google Scholar